Your browser doesn't support javascript.
loading
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer.
Moses, Marcus; Niu, Alex; Lilly, Michael B; Hahn, Andrew W; Nussenzveig, Roberto; Ledet, Elisa; Manogue, Charlotte; Cotogno, Patrick; Lewis, Brian; Layton, Jodi; Agarwal, Neeraj; Sartor, Oliver; Barata, Pedro C.
Affiliation
  • Moses M; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Niu A; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Lilly MB; Medical University of South Carolina, Charleston, SC, USA.
  • Hahn AW; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Nussenzveig R; Huntsman Cancer Institute, University of Utah, Salt Lake, UT, USA.
  • Ledet E; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Manogue C; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Cotogno P; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Lewis B; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Layton J; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake, UT, USA.
  • Sartor O; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA.
  • Barata PC; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans 70112, LA, USA. Electronic address: pbarata@tulane.edu.
Cancer Treat Res Commun ; 24: 100193, 2020.
Article in En | MEDLINE | ID: mdl-32702615
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Prostatic Neoplasms, Castration-Resistant / Circulating Tumor DNA Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Cancer Treat Res Commun Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Prostatic Neoplasms, Castration-Resistant / Circulating Tumor DNA Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Cancer Treat Res Commun Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom